期刊文献+

疏肝泄胆针法治疗偏头痛患者焦虑抑郁症状的临床疗效观察 被引量:7

Clinical Efficacy on Anxiety and Depression of Patients with Migraine Treated with Shugan Xiedan Acupuncture
下载PDF
导出
摘要 目的:观察疏肝泄胆针法治疗偏头痛患者焦虑抑郁症状的临床疗效。方法:将60例伴有焦虑抑郁症状的偏头痛患者随机分为对照组和治疗组,每组各30例。对照组给予双氯芬酸钠缓释片口服,治疗组在口服双氯芬酸钠缓释片的基础上给予疏肝泄胆针法针刺治疗。结果:疏肝泄胆针法对偏头痛患者焦虑抑郁症状的改善程度与对照组比较有统计学差异(P<0.05)。结论:疏肝泄胆针法对于改善偏头痛患者的焦虑抑郁症状具有显著疗效。 Objective:To observe the clinical efficacy on anxiety and depression of patients with migraine trea- ted with Shugan Xiedan acupuncture. Methods:60 cases of migraine associated with anxiety and depressior, were randomized into two groups of treatment group and control group, 30 patients in each group. The control group was treated with diclofenac sodium sustained- release tablets while the treatment group was treated with Shugan Xiedan acupuncture based on diclofenac sodium sustained - release tablets. Results: The degree of im- provement of anxiety and depression in treatment group had a statistically significant difference ( P 〈 0. 05 ) com- pared with that of model control group. Conclusion:Shugan Xiedan acupuncture treatment has a significant effi- cacy on anxiety and depression of patients with migraine.
出处 《针灸临床杂志》 2013年第3期13-14,共2页 Journal of Clinical Acupuncture and Moxibustion
关键词 疏肝泄胆针法 焦虑抑郁 偏头痛 Shugan Xiedan acupuncture Anxiety and depression Migraine
  • 相关文献

参考文献4

二级参考文献28

  • 1[1]Michael A, Meskeowitz, F Michael Cutter. Attacking migraine headachefrom beginning to end[J]. Neurology, 1997,49:1193-1195
  • 2[2]Aunaa SK. Ahmad BK, Welch KMA, et al. Transcranial magneticstimulation confirms hyperexcitability of oecipital cortex in migraine[J]. Neurology, 1998,50:1111-1114
  • 3[3]Bednarczyk EM, Rauler B, et al. Global cerabral blood flow, blood volume and oxygen metabolism in patients with migraine headache [J]. Neurology, 1998,50:1736-1740
  • 4[4]Martin Lanritzen. Pathephysiology of the migraine aura: the spneading epression theory[J]. Brain, 1994,117:199-210
  • 5[5]Peter James Goadsby. Migraine, aura, and cortical spreading depression: why are we still talking about it? [J] Ann Neurol,2001,49:4-6
  • 6[6]Diener HC, Limmroth V. Acute management of migraine triptans andbeyond[J]. Curr Opin Neurol, 1999,12:261-267
  • 7[7]PeterJ. Goadsby, D. Sc., Richard B Lipton, et al. Drug therapy: Migraine-current understanding and treatment[J]. N Engl J Med,2002, 346: 230-245
  • 8[8]Goldstein DJ, Roon KI, Often WW, et al. Selective seratonin IF(5-HF1F)receptor agonist L$334370 for acute migraine: a randomized controlled trial[J]. Lancet,2001,358:1230-1234
  • 9[9]Thansen LL, Olesen J. Nitric oxide theory of migraine [ J]. ClinNenrosci, 1998,49: 28-33
  • 10[10]Stepien A, Chalimoniuk M. Level of nitric oxide-dependent cGMP inpatients with migraine[J]. Cephalalgia, 1998,94:631-634

共引文献135

同被引文献40

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部